FDA Cautions On Use Of Ariad's Iclusig

The Food and Drug Administration issued a safety announcement cautioning doctors to carefully weigh the risks and benefits of Ariad Pharmaceuticals Inc.'s (Nasdaq: ARIA) leukemia treatment Iclusig. The stock price plummeted $1.15 to close at $4.26.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here